Trial intelligence / Profile preview

Effect of Vitamin B12, Folate, and Entacapone in Levodopa-induced Hyperhomocysteinemia

TCTR20181221001Recruiting

Sponsor
Research and Development Center, Prapokklao Hospital
Start
Jan 2019
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Trial of cyanocobalamin, folate, entacapone and levodopa in Parkinson's disease (PD), sponsored by Research and Development Center, Prapokklao Hospital. Started Jan 2019; status: recruiting.

02

Drugs

cyanocobalaminfolateentacaponelevodopa
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on TCTR20181221001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20181221001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call